News | May 12, 2015

SCAI 2015 Case Studies Will Support Value of Accrediation for Cardiovascular Excellence Credentials

ACE cath/PCI labs continually meet highest standards in quality, performance and outcome measures

ACE, accreditation, cath lab, PCI, SCAI 2015, case studies

May 13, 2015 — For the first time, cardiac catheterization laboratory stakeholders now have quality metrics that confirm the value of Accreditation for Cardiovascular Excellence (ACE) accreditation. Three new studies validating the benefits of ACE accreditation were presented during the 2015 Society for Cardiovascular Angiography and Interventions (SCAI) Scientific Sessions in San Diego, California, May 6-9.

In the series of studies, Bonnie H. Weiner, M.D., MSEC, MBA, MSCAI, FACC, and colleagues examined multiple quality, performance and outcome measures among 24 facilities that have achieved full ACE accreditation for their diagnostic cardiac catheterization and percutaneous coronary intervention (cath/PCI) programs; the group also studied four facilities that did not meet the rigorous standards for ACE accreditation.

"We found that ACE-accredited cardiac catheterization laboratories were significantly more likely than non-accredited facilities to meet the highest-quality standards for more than a dozen structural, process-related and procedural domains," said Weiner, ACE's chief medical officer. "These data clarify and support the critical role of ACE accreditation in assisting facilities to provide excellent cardiovascular care."

The studies focused on structural and process domains (Abstract 13849) and case-level procedural characteristics (Abstract 13862) that significantly differentiated ACE-accredited cardiac catheterization laboratories from facilities that did not achieve accreditation. Additional survey data highlighted the perceived value of undergoing the ACE external review and accreditation and process (Abstract 13833).

"More than 90 percent of ACE-accredited facilities feel that accreditation adds substantial value to their organization in terms of improved care quality," Weiner said. "The value proposition of ACE accreditation touches every aspect of the cardiac catheterization laboratory, from enhanced patient safety to improved staff confidence and morale."

Data Presented
Performance on multiple outcomes measures differed significantly between cardiac catheterization laboratories that achieved accreditation through ACE and those that did not initially achieve accreditation, according to fthe data. Overall, outcomes on 11 measures related to appropriate use criteria (AUC), procedural findings, and other metrics were significantly different between invasive cardiac cases performed at accredited versus non-accredited facilities.

To identify potential performance differences between facility types, the investigators compared case data from 1,445 patients undergoing invasive cardiac procedures at 20 ACE-accredited facilities to data from 445 patients treated at 4 facilities that did not meet the rigorous standards for ACE accreditation. All case review data were entered into a uniform case report form and analyzed with standard statistical software (JMP 11.2.0).
 
"We found statistically significant differences across multiple performance domains that distinguish the invasive procedures performed at ACE-accredited cardiac catheterization laboratories from those performed at non-accredited facilities," Weiner said. "These findings demonstrate that ACE-accredited facilities are delivering quality cardiac care that is more likely to be consistent with national standards of cardiovascular excellence."
 
The invasive procedures performed at ACE-accredited facilities were more likely than those at non-accredited facilities to be characterized by diagnostic AUC scored as appropriate (74.1% vs. 57.7%; p<0.0001), adequate opacification (93.1% vs. 82.0%; p<0.0001), and adequate lesion characterization (91.3% vs. 83.8%; p<0.0001).
 
Standardizing the documentation and reporting of key procedural details is critically important for demonstrating appropriate use and medical necessity. Overall case assessments were significantly more likely to be deemed appropriate for the invasive cardiac procedures performed at ACE-accredited facilities compared with those performed at non-accredited facilities (73.6 vs. 63.1%; p<0.0001).
 

For more information: www.cvexcel.org

Related Content

Philips Showcases Integrated Solutions for Cardiovascular Care at TCT 2018
News | Cath Lab | September 20, 2018
At the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting, Sept. 21–25 in San Diego, Philips is showcasing...
Sponsored Content | Videos | Cath Lab | September 19, 2018
William O’Neill, M.D., outlines his recent clinical publication of AMICS patients from the Impella Quality (IQ) datab
Videos | Cath Lab | September 14, 2018
A discussion with Nicolas Bevins, Ph.D., vice chair, physics and research, and Jessica Harrington, RCIS.
A complex PCI case to revascularize a chronic total occlusion (CTO) at Henry Ford Hospital in Detroit. Complex PCI and CHIP cases are increasing patient volumes in the cath lab and using a minimally invasive approach in patients who otherwise would have been sent for CABG. Pictured is Khaldoon Alaswad, M.D. DAIC staff photo by Dave Fornell

A complex PCI case to revascularize a chronic total occlusion (CTO) at Henry Ford Hospital in Detroit. Complex PCI and CHIP cases are increasing patient volumes in the cath lab and using a minimally invasive approach in patients who otherwise would have been sent for CABG. Pictured is Khaldoon Alaswad, M.D. (right) who is proctoring a fellow in treating CTOs.

Feature | Cath Lab | September 13, 2018 | Artur Kim, Kamran Zamanian
Coronary artery disease (CAD) is a multifaceted disease that demands various approaches in terms of diagnosis and tre
Videos | Cath Lab | August 13, 2018
Jeffrey Schussler, M.D., FACC, FSCAI, FSCCT, FACP, interventional cardiologist at Baylor Scott White Heart and Vascul
Shockwave Launches Coronary Intravascular Lithotripsy in Europe
News | Cath Lab | May 30, 2018
Shockwave Medical recently announced the European commercial availability of Intravascular Lithotripsy (IVL) for...
FFR software on the GE Centricity CVIS. A trial from the 2018 EuroPCR meeting showed FFR improves long-term outcomes.
News | Cath Lab | May 29, 2018
May 29, 2018 — Ongoing controversy exists regarding the role of percutaneous coronary intervention (PCI) for stable c
SCAI Updates Consensus on Length of Stay for Percutaneous Coronary Intervention
News | Cath Lab | May 15, 2018
Revised guidelines incorporating new data on discharge criteria for patients undergoing elective percutaneous coronary...
No Benefit Found Using Sodium Bicarbonate, Acetylcysteine to Prevent Kidney Injury, the result of the PRESERVE Trial to prevent acute kidney injury (AKI), presented at SCAI 2018.  #SCAI, #SCAI2018,
Feature | Cath Lab | May 15, 2018
May 15, 2018 – The large-scale, international randomized PRESERVE clinical trial found high-risk patients for renal c
Angiogram of a STEMI patient.
News | Cath Lab | May 15, 2018
May 15, 2018 — A contemporary, real-world analysis shows lower mortality rates when culprit-only intervention is used
Overlay Init